Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Dexmedetomidine
Hospital Authority, Hong Kong
CABG
1 trial -
Dietary intervention + Physical Activity + Monitoring
NORTHWEST BIOTHERAPEUTICS INC
Gestational Diabetes
1 trial -
Disitamab Vedotin combined with Zimberelizumab
The First People's Hospital of Lianyungang
Biliary Carcinoma
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
The First People's Hospital of Lianyungang
Diabetes
1 trial -
EPCs plus PTA
The First People's Hospital of Lianyungang
Diabetic Foot
1 trial -
Early auto-mode
Century Therapeutics
Diabetes Mellitus Type 1 Pre-Existing
1 trial -
EmbryoGlue® (laboratory culture medium)
United Therapeutics Europe Ltd
Infertility
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Fecal Microbiota Transplantation (FMT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 1 Diabetes
1 trial -
Ferrous Fumarate Oral Tablet
Hospital Authority, Hong Kong
Iron Deficiency Anemia Treatment
1 trial -
Fosinopril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Fresh organic vegetables
United Therapeutics Europe Ltd
Diabetes Mellitus, Type 2
1 trial -
Fruit Bar
United Therapeutics Europe Ltd
Bioavailability
1 trial -
Gabapentin
United Therapeutics Europe Ltd
Sciatica
1 trial -
Gabapentin
Hospital Authority, Hong Kong
Spinal Fusion
1 trial -
Gemcitabine
HALOZYME THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
Glimepiride
Takeda
Type 2 Diabetes
1 trial -
Guselkumab
BRIGHT MINDS BIOSCIENCES INC.
Psoriasis Vulgaris
1 trial -
HCQ/CQ and CAB combined treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Resistance, Disease
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
Huangqi Guizhi Wuwu decoction
The First People's Hospital of Lianyungang
Diabetic Nephropathies
1 trial -
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
The First People's Hospital of Lianyungang
CD30+ Peripheral T-cell Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources